Related Experiment Video
Updated: May 2, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility
Angela Gutierrez-Camino1, Elixabet Lopez-Lopez1, Idoia Martin-Guerrero1
1Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Leioa, Spain.
Genetic variations in microRNA genes, specifically rs12803915 in miR-612 and rs3746444 in miR-499, are associated with childhood acute lymphoblastic leukemia (ALL) susceptibility.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Childhood acute lymphoblastic leukemia (ALL) has a suspected inherited genetic risk.
- Most prior research focused on coding regions, neglecting non-coding areas like microRNAs (miRNAs).
- Dysregulated miRNA expression suggests a role in ALL development, potentially influenced by single-nucleotide polymorphisms (SNPs).
Purpose of the Study:
- To investigate if polymorphisms in pre-microRNAs (pre-miRNAs) and miRNA-processing genes contribute to childhood ALL predisposition.
- To identify specific genetic markers associated with ALL risk.
Main Methods:
- Analyzed 118 SNPs in pre-miRNA and miRNA-processing genes.
- Compared genetic data from 213 B-cell ALL patients and 387 healthy controls.
Main Results:
- Identified 11 SNPs significantly associated with ALL susceptibility.
- Three SNPs were in miRNA genes (miR-612, miR-499, miR-449b), and eight were in miRNA biogenesis genes.
- SNPs rs12803915 (in miR-612) and rs3746444 (in miR-499) showed the strongest association (P <0.01).
Conclusions:
- SNP rs12803915 in pre-mir-612 and SNP rs3746444 in pre-mir-499 may serve as novel biomarkers for B-cell ALL susceptibility.
- These findings highlight the importance of non-coding genetic variations in pediatric leukemia.
More Related Videos
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Single Nucleotide Polymorphisms-SNPs
RNA Splicing